Skip to content

SCNI SCINAI IMMUNOTHERAPEUTICS LT

Follow

SPONSORED ADR (ADR), issuer CIK 1611747

6 managers (6 13F filers) reported a position in SCNI shares at 2024-09-30, 2,012 shares in all. 0 filers opened a position and 4 filers sold out during the quarter.

Managers
6
13F filers
6
New
0
Added
1
Reduced
1
Sold out
4
Shares held by filers
2,012

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2024

Filers in the available 13F reports with a share position at 2024-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
RHUMBLINE ADVISERS1,653$5.85K<0.01%+51513F-HRTimeline
MORGAN STANLEYin group MORGAN STANLEY255$880<0.01%013F-HR/ATimelineGroup
CREDIT AGRICOLE S Ain group CREDIT AGRICOLE S A42$145<0.01%013F-HRTimelineGroup
Aspire Private Capital, LLC32$110<0.01%013F-HRTimeline
UBS Group AGin group UBS Group AG30$104<0.01%-18113F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$00%013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.